Novo Nordisk boasts 45 million customers using its drug, which has caused a revolution in weight-loss treatment. But competitors are nipping at its heels.

Telehealth company Hims Hers is pushing the boundaries of drug compounding and testing the limits of regulators.

Telehealth provider Hims & Hers Health is defending its planned Super Bowl ad, which is styled as a political manifesto ...

Healthcare stocks have something to offer every investor. If you're looking for high growth, you can try an innovative ...